Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stempeucel in Critical Limb Ischemia (Buerger's Disease)
NCT01484574Phase 2Completed
- Sponsor
- Stempeutics Research
- Start
- Jan 2012
- Primary completion
- Feb 2014
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Stempeucel in thromboangiitis obliterans (TAO), critical limb ischemia (CLI), sponsored by Stempeutics Research. Started Jan 2012; status: completed.
02
Drugs
Stempeucel
03
Conditions
thromboangiitis obliterans (TAO)critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT01484574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01484574.